id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-6016-0006,FDA,FDA-2017-E-6016,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PARSABIV",Notice,Determinations,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,2019-02-27T04:59:59Z,2019-01-09T02:01:46Z,2018-28221,0,0,09000064839d2140
FDA-2017-E-6017-0006,FDA,FDA-2017-E-6017,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PARSABIV",Notice,Determinations,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,2019-02-27T04:59:59Z,2018-12-31T23:00:56Z,2018-28221,0,0,09000064839d2141
FDA-2017-E-6708-0006,FDA,FDA-2017-E-6708,Determinations of Regulatory Review Periods for Purposes of Patent Extensions: RYDAPT,Notice,Determinations,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,2019-06-27T03:59:59Z,2024-03-07T21:12:00Z,2018-28216,0,0,09000064839d2146
FDA-2015-N-0101-1463,FDA,FDA-2015-N-0101,Meeting Granted Letter from FDA CDER to Cardinal Health,Other,Approval,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,,2018-12-31T22:18:50Z,,0,0,09000064839d240f
FDA-2017-E-6701-0006,FDA,FDA-2017-E-6701,Determinations of Regulatory Review Periods for Purposes of Patent Extensions: RYDAPT,Notice,Determinations,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,2019-06-27T03:59:59Z,2024-03-07T21:19:56Z,2018-28216,0,0,09000064839d2147
FDA-2016-P-1962-0006,FDA,FDA-2016-P-1962,"Letter from FDA CDER to Hyman, Phelps, and McNamara, P.C.",Other,Partial Petition Approval and Denial,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,,2018-12-31T22:07:39Z,,0,0,09000064839d2016
FDA-2018-H-4831-0001,FDA,FDA-2018-H-4831,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:16:15Z,,0,0,09000064839c9f85
FDA-2018-H-4848-0001,FDA,FDA-2018-H-4848,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:43:41Z,,0,0,09000064839cc441
FDA-2018-H-4820-0001,FDA,FDA-2018-H-4820,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:38:02Z,,0,0,09000064839c9c63
FDA-2018-H-4840-0001,FDA,FDA-2018-H-4840,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:51:50Z,,0,0,09000064839cc8a4
FDA-2018-H-4817-0001,FDA,FDA-2018-H-4817,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:20:01Z,,0,0,09000064839c9c19
FDA-2018-H-4822-0001,FDA,FDA-2018-H-4822,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:59:16Z,,0,0,09000064839ca125
FDA-2018-H-4852-0001,FDA,FDA-2018-H-4852,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:40:52Z,,0,0,09000064839cc629
FDA-2007-D-0369-0459,FDA,FDA-2007-D-0369,"Product-Specific Guidance for Linaclotide; Draft Guidance for
Industry",Notice,Notice of Availability,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2019-02-27T02:04:39Z,2018-28213,0,0,09000064839cbf71
FDA-2018-H-4850-0001,FDA,FDA-2018-H-4850,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:33:00Z,,0,0,09000064839cc5da
FDA-2018-H-4844-0001,FDA,FDA-2018-H-4844,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:40:36Z,,0,0,09000064839cca11
FDA-2018-H-4818-0001,FDA,FDA-2018-H-4818,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:25:19Z,,0,0,09000064839c9c34
FDA-2018-H-4855-0001,FDA,FDA-2018-H-4855,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:56:09Z,,0,0,09000064839ccbc2
FDA-2018-H-4809-0001,FDA,FDA-2018-H-4809,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:32:37Z,,0,0,09000064839c9419
FDA-2018-H-4837-0001,FDA,FDA-2018-H-4837,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T14:12:19Z,,0,0,09000064839cbb58
FDA-2018-H-4830-0001,FDA,FDA-2018-H-4830,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:12:50Z,,0,0,09000064839c9c0b
FDA-2018-H-4835-0001,FDA,FDA-2018-H-4835,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:27:00Z,,0,0,09000064839cb843
FDA-2018-H-4859-0001,FDA,FDA-2018-H-4859,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:55:17Z,,0,0,09000064839cc998
FDA-2017-E-6003-0006,FDA,FDA-2017-E-6003,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PARSABIV",Notice,Determinations,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2018-12-31T21:10:48Z,2018-28221,0,0,09000064839cbe98
FDA-2018-D-4662-0001,FDA,FDA-2018-D-4662,International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV,Notice,Notice of Availability,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2019-01-14T19:29:13Z,2018-28219,0,0,09000064839cbf33
FDA-2018-N-3037-0002,FDA,FDA-2018-N-3037,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Generic Clearance
for Quantitative Testing for the Development of Food and Drug
Administration Communications",Notice,30 Day Proposed Information Collection,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-01-29T04:59:59Z,2019-01-10T02:46:59Z,2018-28252,0,0,09000064839cbd39
FDA-2018-H-4836-0001,FDA,FDA-2018-H-4836,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T14:10:49Z,,0,0,09000064839cc150
FDA-2018-H-4857-0001,FDA,FDA-2018-H-4857,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T17:16:40Z,,0,0,09000064839ccd6d
FDA-2018-H-4819-0001,FDA,FDA-2018-H-4819,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:27:47Z,,0,0,09000064839c9bca
FDA-2018-H-4808-0001,FDA,FDA-2018-H-4808,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:31:48Z,,0,0,09000064839c95f2
FDA-2018-H-4821-0001,FDA,FDA-2018-H-4821,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T12:40:14Z,,0,0,09000064839ca0c0
FDA-2018-H-4849-0001,FDA,FDA-2018-H-4849,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:28:25Z,,0,0,09000064839cc537
FDA-2017-E-6736-0005,FDA,FDA-2017-E-6736,"Determination of Regulatory Review Period for Purposes of Patent
Extension; XERMELO",Notice,Determinations,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2018-12-31T21:26:53Z,2018-28218,0,0,09000064839cbee3
FDA-2012-N-0197-0005,FDA,FDA-2012-N-0197,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Medical Devices; Shortages Data Collection System",Notice,Request for Comments,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2018-12-31T20:58:41Z,2018-28235,0,0,09000064839cbe96
FDA-2017-E-6002-0006,FDA,FDA-2017-E-6002,"Determination of Regulatory Review Period for Purposes of Patent
Extension; RUBRACA",Notice,Determinations,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2018-12-31T21:05:16Z,2018-28217,0,0,09000064839cbe97
FDA-2018-H-4858-0001,FDA,FDA-2018-H-4858,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T17:17:18Z,,0,0,09000064839ccdd9
FDA-2018-H-4856-0001,FDA,FDA-2018-H-4856,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:57:22Z,,0,0,09000064839ccbdc
FDA-2018-H-4843-0001,FDA,FDA-2018-H-4843,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:56:45Z,,0,0,09000064839ccd08
FDA-2012-N-0536-0008,FDA,FDA-2012-N-0536,"Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device User Fee Cover Sheet, Form FDA 3601",Notice,60 Day Proposed Information Collection,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-02-27T04:59:59Z,2019-07-17T12:49:50Z,2018-28220,0,0,09000064839cc098
FDA-2018-H-4833-0001,FDA,FDA-2018-H-4833,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:19:51Z,,0,0,09000064839cb83d
FDA-2018-H-4861-0001,FDA,FDA-2018-H-4861,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:11:58Z,,0,0,09000064839cca33
FDA-2018-H-4853-0001,FDA,FDA-2018-H-4853,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:47:44Z,,0,0,09000064839cc95c
FDA-2018-H-4834-0001,FDA,FDA-2018-H-4834,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:23:12Z,,0,0,09000064839ca3b1
FDA-2018-H-4854-0001,FDA,FDA-2018-H-4854,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:41:22Z,,0,0,09000064839ccb70
FDA-2017-E-6700-0006,FDA,FDA-2017-E-6700,Determinations of Regulatory Review Periods for Purposes of Patent Extensions: RYDAPT,Notice,Determinations,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,2019-06-27T03:59:59Z,2024-03-07T21:04:21Z,2018-28216,0,0,09000064839cbfba
FDA-2018-H-4842-0001,FDA,FDA-2018-H-4842,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T16:54:39Z,,0,0,09000064839ccb78
FDA-2018-H-4838-0001,FDA,FDA-2018-H-4838,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T14:13:06Z,,0,0,09000064839cc18d
FDA-2018-H-4860-0001,FDA,FDA-2018-H-4860,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:56:00Z,,0,0,09000064839cc9cc
FDA-2018-H-4810-0001,FDA,FDA-2018-H-4810,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T13:46:22Z,,0,0,09000064839c944d
FDA-2018-H-4846-0001,FDA,FDA-2018-H-4846,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:30:01Z,,0,0,09000064839cc502
FDA-2018-H-4847-0001,FDA,FDA-2018-H-4847,Complaint,Other,Complaint,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2018-12-28T15:33:36Z,,0,0,09000064839cc508
FDA-2018-H-4788-0001,FDA,FDA-2018-H-4788,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:33:57Z,,0,0,09000064839c81e3
FDA-2018-H-4794-0001,FDA,FDA-2018-H-4794,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:50:26Z,,0,0,09000064839c7f4e
FDA-2018-H-4791-0001,FDA,FDA-2018-H-4791,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T12:46:32Z,,0,0,09000064839c723d
FDA-2018-H-4781-0001,FDA,FDA-2018-H-4781,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T12:51:27Z,,0,0,09000064839c7235
FDA-2018-H-4797-0001,FDA,FDA-2018-H-4797,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T14:06:15Z,,0,0,09000064839c7fdf
FDA-2018-H-4803-0001,FDA,FDA-2018-H-4803,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T16:57:22Z,,0,0,09000064839c8cfd
FDA-2018-H-4829-0001,FDA,FDA-2018-H-4829,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:13:22Z,,0,0,09000064839c9d74
FDA-2017-F-2130-0016,FDA,FDA-2017-F-2130,"Food Additives Permitted in Feed and Drinking Water of Animals; Formic
Acid",Rule,Final Rule,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-31T20:44:12Z,2018-27966,0,0,09000064839c8864
FDA-2018-H-4795-0001,FDA,FDA-2018-H-4795,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:57:39Z,,0,0,09000064839c7f54
FDA-2018-H-4799-0001,FDA,FDA-2018-H-4799,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T15:06:54Z,,0,0,09000064839c89ef
FDA-2018-H-4824-0001,FDA,FDA-2018-H-4824,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:00:22Z,,0,0,09000064839c9ab2
FDA-2018-H-4775-0001,FDA,FDA-2018-H-4775,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T12:56:05Z,,0,0,09000064839c7094
FDA-2018-H-4798-0001,FDA,FDA-2018-H-4798,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T14:09:39Z,,0,0,09000064839c823d
FDA-2018-H-4796-0001,FDA,FDA-2018-H-4796,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T14:02:12Z,,0,0,09000064839c7fa8
FDA-2018-H-4786-0001,FDA,FDA-2018-H-4786,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:10:53Z,,0,0,09000064839c6fd5
FDA-2018-H-4784-0001,FDA,FDA-2018-H-4784,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:25:14Z,,0,0,09000064839c6f94
FDA-2018-H-4787-0001,FDA,FDA-2018-H-4787,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:07:56Z,,0,0,09000064839c6fdb
FDA-2018-H-4789-0001,FDA,FDA-2018-H-4789,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:51:44Z,,0,0,09000064839c7fd6
FDA-2018-H-4825-0001,FDA,FDA-2018-H-4825,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:32:19Z,,0,0,09000064839c9bfc
FDA-2018-H-4813-0001,FDA,FDA-2018-H-4813,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T19:05:53Z,,0,0,09000064839c973d
FDA-2018-N-1989-0001,FDA,FDA-2018-N-1989,Ranjan Bhandari: Debarment Order,Notice,Statutory Debarment,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-31T20:39:45Z,2018-27951,0,0,09000064839c8820
FDA-2018-H-4762-0001,FDA,FDA-2018-H-4762,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:01:33Z,,0,0,09000064839c6e2c
FDA-2018-H-4792-0001,FDA,FDA-2018-H-4792,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T12:49:14Z,,0,0,09000064839c7265
FDA-2018-H-4807-0001,FDA,FDA-2018-H-4807,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T18:10:20Z,,0,0,09000064839c9367
FDA-2018-H-4785-0001,FDA,FDA-2018-H-4785,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:29:51Z,,0,0,09000064839c6fc3
FDA-2018-H-4802-0001,FDA,FDA-2018-H-4802,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T17:06:32Z,,0,0,09000064839c9121
FDA-2018-H-4826-0001,FDA,FDA-2018-H-4826,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:44:27Z,,0,0,09000064839c9c2e
FDA-2018-H-4793-0001,FDA,FDA-2018-H-4793,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:44:48Z,,0,0,09000064839c7b76
FDA-2018-H-4801-0001,FDA,FDA-2018-H-4801,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T16:52:09Z,,0,0,09000064839c8ea7
FDA-2018-H-4800-0001,FDA,FDA-2018-H-4800,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T15:09:05Z,,0,0,09000064839c8b0c
FDA-2018-H-4814-0001,FDA,FDA-2018-H-4814,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:18:22Z,,0,0,09000064839c9bd2
FDA-2018-H-4823-0001,FDA,FDA-2018-H-4823,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T21:30:43Z,,0,0,09000064839ca200
FDA-2018-H-4790-0001,FDA,FDA-2018-H-4790,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T13:57:45Z,,0,0,09000064839c822f
FDA-2018-H-4806-0001,FDA,FDA-2018-H-4806,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T17:42:35Z,,0,0,09000064839c91d7
FDA-2018-H-4805-0001,FDA,FDA-2018-H-4805,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T17:12:55Z,,0,0,09000064839c9127
FDA-2018-H-4811-0001,FDA,FDA-2018-H-4811,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T17:01:13Z,,0,0,09000064839c8e17
FDA-2018-H-4816-0001,FDA,FDA-2018-H-4816,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T20:25:54Z,,0,0,09000064839c9bdb
FDA-2018-H-4828-0001,FDA,FDA-2018-H-4828,Complaint,Other,Complaint,2018-12-27T05:00:00Z,2018,12,2018-12-27T05:00:00Z,,2018-12-27T21:27:43Z,,0,0,09000064839ca11f
FDA-2018-N-4428-0001,FDA,FDA-2018-N-4428,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Medicated Feed Mill License Application",Notice,60 Day Proposed Information Collection,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,2019-02-26T04:59:59Z,2019-01-10T02:17:47Z,2018-27812,0,0,09000064839c4daf
FDA-2018-H-4688-0001,FDA,FDA-2018-H-4688,Complaint,Other,Complaint,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,,2018-12-26T20:59:50Z,,0,0,09000064839c6c73
FDA-2017-D-3001-0235,FDA,FDA-2017-D-3001,"Modified Risk Tobacco Product Applications for IQOS System With Marlboro Heatsticks, IQOS System With Marlboro Smooth Menthol
Heatsticks, and IQOS System With Marlboro Fresh Menthol Heatsticks
Submitted by Philip Morris Products S.A.",Notice,Announcement,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,2019-02-12T04:59:59Z,2019-02-27T02:06:18Z,2018-27807,0,0,09000064839c4e5f
FDA-2017-E-5040-0006,FDA,FDA-2017-E-5040,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ADLYXIN",Notice,Determinations,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,2019-02-26T04:59:59Z,2019-01-10T02:33:03Z,2018-27805,0,0,09000064839c4db3
FDA-2018-H-4782-0001,FDA,FDA-2018-H-4782,Complaint,Other,Complaint,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,,2018-12-26T20:18:56Z,,0,0,09000064839c6a72
FDA-2014-N-1210-3431,FDA,FDA-2014-N-1210,Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses,Rule,Final Rule,2018-12-26T05:00:00Z,2018,12,2018-12-26T05:00:00Z,,2019-01-10T02:12:36Z,2018-27809,0,0,09000064839c4d26
FDA-2018-D-4455-0001,FDA,FDA-2018-D-4455,"Developing and Submitting Proposed Draft Guidance Relating to Patient
Experience Data; Draft Guidance for Industry and Other Stakeholders;
Availability",Notice,Notice of Availability,2018-12-21T05:00:00Z,2018,12,2018-12-21T05:00:00Z,2019-03-22T03:59:59Z,2019-03-23T01:00:52Z,2018-27657,0,0,09000064839be12e
FDA-2017-E-3616-0006,FDA,FDA-2017-E-3616,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-12-21T05:00:00Z,2018,12,2018-12-21T05:00:00Z,,2018-12-21T18:23:37Z,,0,0,09000064839c0871
FDA-2016-D-4308-0026,FDA,FDA-2016-D-4308,04 Reference 3 Compliance Program Guidance Manual Chapter 42 Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors,Supporting & Related Material,Background Material,2018-12-21T05:00:00Z,2018,12,,,2018-12-21T14:36:48Z,,0,0,09000064839beb23
FDA-2016-D-4308-0023,FDA,FDA-2016-D-4308,01 RBC Antigen_Reference List,Supporting & Related Material,Background Material,2018-12-21T05:00:00Z,2018,12,,,2018-12-21T14:34:03Z,,0,0,09000064839beb20
FDA-2017-E-5694-0006,FDA,FDA-2017-E-5694,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-12-21T05:00:00Z,2018,12,2018-12-21T05:00:00Z,,2018-12-21T18:17:49Z,,0,0,09000064839c07c8